微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.31% | 20.36% | 90.23% | 79/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.74% | 34.88% | 132% | 88/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.75% | 17.19% | -68.09% | 96/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.35% | 172.76% | -14.55% | 83/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.75% | 231.33% | 113.18% | 95/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.29% | 4200% | 101.56% | 96/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.64% | 256.1% | 119.81% | 106/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -3.23% | 55.93% | -489.16% | 116/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.83% | 127.85% | 2666.67% | 108/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.03% | -95.31% | 107.32% | 116/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.41% | -5.13% | 94.41% | 117/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -7.33% | -923.6% | -145.97% | 126/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.98% | -322.39% | -565.63% | 123/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.64% | 33.33% | 264.1% | 113/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.39% | 62.5% | -143.82% | 111/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.89% | -76.46% | -33.58% | 104/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 1.34% | -77.85% | 179.17% | 95/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.48% | -76.35% | 146.15% | 104/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.04% | -226.83% | -127.51% | 96/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.78% | 709.68% | -37.52% | 98/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.05% | 1.17% | 198.03% | 59/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.03% | 27.67% | 147.56% | 87/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.82% | 64% | 232.26% | 88/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -0.62% | -237.78% | -110.37% | 121/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.98% | 348.13% | 276.1% | 54/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.59% | 126.86% | 218% | 88/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.5% | 119.38% | 11.11% | 91/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.45% | 0% | 118.67% | 115/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | -2.41% | -449.28% | 59.29% | 98/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | -5.92% | -51.02% | -129.46% | 103/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -2.58% | -27.09% | -673.33% | 89/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.45% | 106.11% | -34.78% | 104/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.69% | -97% | 117.6% | 76/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -3.92% | 34.12% | -93.1% | 89/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -2.03% | 34.52% | 72.46% | 80/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -7.37% | 12.16% | -132.06% | 101/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 22.99% | 549.02% | 486.39% | 3/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -5.95% | 29.83% | -91.94% | 81/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -3.1% | 33.19% | 63.05% | 73/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | -8.39% | 73.35% | -63.87% | 98/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | -5.12% | -126.55% | 39.62% | 68/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | -8.48% | -131.06% | -82.76% | 70/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | -4.64% | -243.7% | 85.26% | 69/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |